Latin America Nuclear Medicine Market Size & Outlook
The nuclear medicine market in Latin America is expected to reach a projected revenue of US$ 2,250.5 million by 2033. A compound annual growth rate of 7.1% is expected of Latin America nuclear medicine market from 2026 to 2033.
The Latin America nuclear medicine market generated a revenue of USD 1,226.6 million in 2025.
The market is expected to grow at a CAGR of 7.1% from 2026 to 2033.
In terms of segment, diagnostics was the largest revenue generating product in 2025.
Diagnostics is the most lucrative product segment registering the fastest growth during the forecast period.
Country-wise, Argentina is expected to register the highest CAGR from 2026 to 2033.
Latin America data book summary
Market revenue in 2025
USD 1,226.6 million
Market revenue in 2033
USD 2,250.5 million
Growth rate
7.1% (CAGR from 2026 to 2033)
Largest segment
Diagnostics
Fastest growing segment
Diagnostics
Historical data covered
2021 - 2024
Base year for estimation
2025
Forecast period covered
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Diagnostics, Therapeutics
Key market players worldwide
GE HealthCare Technologies Inc Common Stock, Jubilant Pharmova, Nordion, Bracco, Iren SpA, Abliva AB, Lantheus Holdings Inc, Eckert & Ziegler Bebig SA, Mallinckrodt PLC Ordinary Shares - New, Cardinal Health Inc
Other key industry trends
In terms of revenue, Latin America region accounted for 5.8% of the global nuclear medicine market in 2025.
Globally, North America is projected to lead the regional market in terms of revenue in 2033.
Asia Pacific is the fastest growing regional market and is projected to reach USD 8,594.5 million by 2033.
Increasing government support to meet medical needs pertaining to nuclear medicines is expected to drive market growth in Latin America. The International Atomic Energy Agency (IAEA)’s 5-year Technical Cooperation Programme has helped Latin American countries grow at a significant rate in the field of nuclear medicine.
Moreover, increasing prevalence of cancer and cardiovascular diseases is expected to boost the demand for advanced nuclear medicine diagnostic and therapeutic technologies. The growth of the Latin America Nuclear Imaging Market is mainly driven by factors such as increasing utilization of SPECT and PET examination in radiopharmaceuticals.
The increase in healthcare expenditure has positively impacted the demand for nuclear imaging devices. For instance, as of October 2020, the Brazilian government spent over 120 billion Brazilian Real (approximately USD 22 billion) on healthcare.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Nuclear Medicine Market Outlook will help companies and investors design strategic landscapes.
Diagnostics was the largest segment with a revenue share of 87.58% in 2025.
Horizon Databook has segmented the Latin America nuclear medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2021 to 2033.
Increasing government support to meet medical needs pertaining to nuclear medicines is expected to drive market growth in Latin America. The International Atomic Energy Agency (IAEA)’s 5-year Technical Cooperation Programme has helped Latin American countries grow at a significant rate in the field of nuclear medicine.
Moreover, increasing prevalence of cancer and cardiovascular diseases is expected to boost the demand for advanced nuclear medicine diagnostic and therapeutic technologies. The growth of the Latin America Nuclear Imaging Market is mainly driven by factors such as increasing utilization of SPECT and PET examination in radiopharmaceuticals.
The increase in healthcare expenditure has positively impacted the demand for nuclear imaging devices. For instance, as of October 2020, the Brazilian government spent over 120 billion Brazilian Real (approximately USD 22 billion) on healthcare.
Latin America Nuclear Medicine Market Product Outlook (Revenue, USD Million , 2021-2033)
Diagnostics
Therapeutics
Latin America Nuclear Medicine Market Application Outlook (Revenue, USD Million , 2021-2033)
Cardiology
Neurology
Oncology
Thyroid
Lymphoma
Bone Metastasis
Endocrine Tumor
Pulmonary Scans
Urology
Other
Latin America Nuclear Medicine Market End Use Outlook (Revenue, USD Million , 2021-2033)
Hospitals
Diagnostic Centers
Others
Reasons to subscribe to Nuclear Medicine Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Nuclear Medicine Market Outlook databook
Our clientele includes a mix of Nuclear Medicine Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America Nuclear Medicine Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Latin America Nuclear Medicine Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Latin America Nuclear Medicine Market, 2021-2033 (US$M)